← All Aytu Biopharma, INC filings

Aytu Biopharma, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NASDAQ
AYTU
Aytu Biopharma, INC
S-1MEF: Aytu BioPharma Increases Public Offering Size by $2.76 Million Through New SEC Filing
Aytu BioPharma, Inc. has filed a Rule 462(b) registration statement to increase the maximum aggregate offering price of its ongoing public offering by an additional $2.76 million, bringing the total potential offering to $16.56 million.
NASDAQ
AYTU
Aytu Biopharma, INC
S-1/A: Aytu BioPharma Files Amended S-1 Registration Statement, Adjusts Offering Fees and Delays Effectiveness
Aytu BioPharma, Inc. filed an Amendment No. 1 to its S-1 Registration Statement, primarily to update the filing fee table for a proposed offering of common stock and prefunded warrants, and to delay the effective date.
NASDAQ
AYTU
Aytu Biopharma, INC
S-1: Aytu BioPharma Announces Public Offering, Strategic Shift to MDD Treatment, and Ongoing Patent Litigation
Aytu BioPharma, Inc. has filed an S-1 registration statement for a public offering of common stock and prefunded warrants, detailing its strategic pivot to focus on prescription therapeutics, including a new exclusive commercialization agreement for a Major Depressive Disorder treatment, alongside mixed financial results and ongoing patent litigation.